Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Qiagen N.V. (QGEN)

Qiagen N.V. (QGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Qiagen: Q1 Earnings Snapshot

Qiagen: Q1 Earnings Snapshot

QGEN : 40.58 (-0.29%)
3 Unusually Active Call Options to Buy With Just 5% Down

Investors continue to wonder how long stocks will keep moving higher. Friday’s jobs report suggests the economy is much stronger than most people realize, which is good news for stocks.

QGEN : 40.58 (-0.29%)
MSFT : 460.77 (+0.32%)
AAPL : 221.55 (+0.58%)
BRK.B : 405.77 (-0.33%)
NVDA : 128.28 (+4.57%)
Qiagen: Q4 Earnings Snapshot

Qiagen: Q4 Earnings Snapshot

QGEN : 40.58 (-0.29%)
Qiagen: Q3 Earnings Snapshot

Qiagen: Q3 Earnings Snapshot

QGEN : 40.58 (-0.29%)
Qiagen: Q2 Earnings Snapshot

Qiagen: Q2 Earnings Snapshot

QGEN : 40.58 (-0.29%)
Qiagen: Q1 Earnings Snapshot

Qiagen: Q1 Earnings Snapshot

QGEN : 40.58 (-0.29%)
QIAGEN Announces Form 20-F Annual Report Filing for 2022 Results

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has filed its annual report, including its audited consolidated financial statements on Form 20-F, for the year ended December...

QGEN : 40.58 (-0.29%)
QIAGEN and Servier Partner to Develop Companion Diagnostic for Acute Myeloid Leukemia (AML) Therapy Drug

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced it has entered into a strategic partnership with Servier, a global pharmaceutical group, to develop a companion diagnostic test for...

QGEN : 40.58 (-0.29%)
SOPHiA GENETICS and QIAGEN Forge Partnership to Combine Strengths in Next-generation Sequencing

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company in the healthcare space, today announced a new partnership with QIAGEN N.V. (NYSE: QGEN) that will pair QIAseq reagent technology with the...

QGEN : 40.58 (-0.29%)
SOPH : 4.66 (+1.53%)
QIAGEN and SOPHiA GENETICS Forge Partnership to Combine Strengths in Next-Generation Sequencing

QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of the new QIAseq Platform Partnership program and the first partnership with medical data-analysis provider SOPHiA GENETICS...

QGEN : 40.58 (-0.29%)
SOPH : 4.66 (+1.53%)

Barchart Exclusives

Where are Animal Proteins Prices Heading in Q3 and Beyond?
The animal protein sector of the commodities market, including live and feeder cattle and lean hog futures, edged marginally higher in Q2. Meats are now in the middle of the peak demand season, when prices tend to reach annual highs. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar